U.S., April 5 -- ClinicalTrials.gov registry received information related to the study (NCT06911385) titled 'Augmenting Cerebral Blood Flow in Acute Ischemic Stroke' on March 28.
Brief Summary: The most common type of stroke is ischemic (lack of blood flow to the brain due to a clot blocking a blood vessel). Time is brain and an average of 1.9 million brain nerve cells per minute are destroyed in patients experiencing a typical LVO. The main goal of treatment is to help restore blood flow as quickly as possible and prevent brain tissue and cell death. Acute treatments like clot-busting medication or clot removal by wire are standard of care but are available in comprehensive stroke centers in a few urban centers. Often, patients need to be...